Search

Oral Cancer

AHNS-002

THE ROLE OF POSTOPERATIVE STIMULATED SERUM THYROGLOBULIN MEASUREMENT FOR PREDICTING RECURRENCE IN PATIENTS WITH PAPILLARY THYROID CANCER: AN ANALYSIS INVOLVING 1,319 PATIENTS

Endocrine

Andre Ywata De Carvalho, MD, MBA, Hugo Fontain Kohler, MD, PHD, Renan Bezerra Lira, MD, PHD, Thiago Celestino Chulam, MD, PHD, Luiz Paulo Kowalski, MD, PHD

A.C.Camargo Cancer Center


AHNS-003

UTILIZING A HIGH-THROUGHPUT APPROACH TO IDENTIFY EFFECTIVE SYSTEMIC AGENTS FOR AGGRESSIVE THYROID CANCER VARIANTS

Endocrine

Abdallah S Mohamed, MD1, Ying Henderson1, Yunyun Chen1, Clifford Stephan2, Gilbert Cote1, Maria Cabanillas1, Mark Zafereo1, Vlad Sandulache3, Stephen Y Lai1

1MD Anderson Cancer Center, 2Institute of Biosciences and Technology, Texas A&M University, 3Baylor College of Medicine


AHNS-005

EVALUATING THYROID CANCER INCIDENCE AND MINNESOTAN RESIDENTIAL RADON CONCENTRATION

Endocrine

Curtis Hanba, MD, Margaret Engelhardt, MD, Sobia Khaja, MD, Emiro Caicedo-Granados, MD

The University of Minnesota - Department of Otolaryngology


AHNS-006

REFINING THE IDENTIFICATION OF A PRECISE CUT POINT FOR THE ASSOCIATION BETWEEN ANNUAL SURGEON TOTAL THYROIDECTOMY VOLUME AND COMPLICATIONS

Endocrine

Charles Metzer, MD1, Michaela Hull, MS2, John L Adams, PhD2

1The Permanente Medical Group, 2Kaiser Permanente, Center for Effectiveness and Safety Research


AHNS-007

THE USE AND IMPACT OF TECHNOLOGY IN THYROIDECTOMIES: A 2016 NSQIP ANALYSIS

Endocrine

Sina J Torabi, BA, Parsa P Salehi, MD, Fouad Chouairi, BS, Yan Lee, MD

Yale School of Medicine, Department of Surgery (Section of Otolaryngology)


AHNS-QS-103

VERACYTE/AFIRMA GEC SUSPICIOUS FOR MALIGNANCY DIAGNOSIS VS. ACADEMIC TERTIARY CARE CENTER BENIGN THYROID CYTOLOGY RESULT. WHAT’S THE RISK OF MALIGNANCY??

Endocrine

Rohit Ranganath, MD1, Derek Allison, MD1, Vaninder K Dhillon, MD1, Jonathon O Russell, MD1, Erin A Felger, MD2, Syed Z Ali1, Ralph P Tufano, MD1

1Johns Hopkins Hospital, 2Medstar Health


D008

POST-THYROIDECTOMY PTH TESTING AND MISSED OPPORTUNITIES IN PREVENTING HYPOCALCEMIA: ARE WE FAILING THE TEST?

Endocrine

Aru Panwar, MD, FACS1, Robert Lindau, MD, FACS1, Harlan Sayles, MS2, Andrew Coughlin, MD, FACS1, Daniel Lydiatt, MD, DDS, FACS1, Oleg Militsakh, MD, FACS1, Angela Osmolak, MD1, Wiliiam Lydiatt, MD, FACS1

1Methodist Estabrook Cancer Center, Nebraska Methodist Hospital, Omaha, Nebraska, 2College of Public Health, University of Nebraska Medical Center, Omaha, Nebraska


D009

NORMOCALCEMIC PRIMARY HYPERPARATHYROIDISM: A SYSTEMATIC REVIEW AND META-ANALYSIS ON LABORATORY VALUES

Endocrine

Blake R Hollowoa, MD, Horace J Spencer, MS, Brendan, Jr. C Stack, MD, FACS, FACE

University of Arkansas for Medical Sciences


D010

THE EFFECT OF IV ACETAMINOPHEN ON PAIN CONTROL IN THYROID AND PARATHYROID SURGERY

Endocrine

Mueez Qureshi, MD1, Catherine Lumley, MD2, Bruce Davidson, MD, FACS1

1Georgetown University Hospital, 2University of North Carolina Chapel Hill


D011

RETROAURICULAR THYROIDECTOMY WITH A NEXT-GENERATION SINGLE-PORT ROBOTIC SURGERY SYSTEM: PRECLINICAL STUDIES AND FIRST IN HUMAN CASE

Endocrine

Tyler Okland, MD1, Myung-Chul Lee, MD2, Kenric Tam, MD3, Estelle Chang, MD4, Eun Chang Choi, MD5, Floyd Christopher Holsinger, MD1, Yoon Woo Koh, MD5

1Stanford University, 2Korea Cancer Center Hospital, 3University of California -- Los Angeles School of Medicine, 4University of Nebraska, 5Yonsei University